Trial intelligence / Profile preview

Omega-3 Fatty Acid-Based Parenteral Nutrition for Postoperative Recovery in Liver Cancer

NCT02321202Phase 4Completed

Sponsor
Huazhong University of Science and Technology
Start
Mar 2010
Primary completion
Sep 2013
Modality
Lipid-based Nanoparticles
Countries
1
01

Overview

A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in liver cancer, Cirrhosis, sponsored by Huazhong University of Science and Technology. Started Mar 2010; status: completed.

02

Drugs

eicosapentaenoic acid + docosahexaenoic acid
03

Conditions

liver cancerCirrhosis

Beyond the preview

Go deeper on NCT02321202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02321202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call